C Gobbi

Summary

Affiliation: Oncology Institute of Southern Switzerland
Country: Switzerland

Publications

  1. doi request reprint Treatment satisfaction, adherence and behavioral assessment in patients de - escalating from natalizumab to interferon beta
    Chiara Zecca
    Neurocentre of Southern Switzerland, Ospedale Regionale di Lugano, Lugano, Switzerland
    BMC Neurol 14:38. 2014
  2. pmc Awareness of headache and of National Headache Society activities among primary care physicians - a qualitative study
    Andreas R Gantenbein
    Neurorehabilitation, RehaClinic Bad Zurzach, Quellenstrasse 34, Bad Zurzach, CH 5330, Switzerland
    BMC Res Notes 6:118. 2013
  3. pmc Interferon beta 1b following natalizumab discontinuation: one year, randomized, prospective, pilot trial
    Claudio Gobbi
    Neurocenter of Southern Switzerland, Ospedale Regionale di Lugano, Lugano, Switzerland
    BMC Neurol 13:101. 2013
  4. ncbi request reprint Restless legs syndrome in multiple sclerosis
    Chiara Zecca
    Neurocenter of Southern Switzerland, Civic Hospital, Lugano, Switzerland
    CNS Neurol Disord Drug Targets 11:1061-9. 2012
  5. doi request reprint Percutaneous posterior tibial nerve stimulation as an effective treatment of refractory lower urinary tract symptoms in patients with multiple sclerosis: preliminary data from a multicentre, prospective, open label trial
    C Gobbi
    Neurocentre of Southern Switzerland, Ente Ospedaliero Cantonale, Ospedale Regionale di Lugano, Lugano, Switzerland
    Mult Scler 17:1514-9. 2011
  6. doi request reprint Maintenance percutaneous posterior nerve stimulation for refractory lower urinary tract symptoms in patients with multiple sclerosis: an open label, multicenter, prospective study
    C Zecca
    Neurocentre of Italian Switzerland, Lugano, Switzerland
    J Urol 191:697-702. 2014
  7. doi request reprint Motor and sensory responses after percutaneous tibial nerve stimulation in multiple sclerosis patients with lower urinary tract symptoms treated in daily practice
    C Zecca
    Neurocenter of Southern Switzerland, Ospedale Regionale di Lugano, Lugano, Switzerland
    Eur J Neurol 21:506-11. 2014

Collaborators

Detail Information

Publications7

  1. doi request reprint Treatment satisfaction, adherence and behavioral assessment in patients de - escalating from natalizumab to interferon beta
    Chiara Zecca
    Neurocentre of Southern Switzerland, Ospedale Regionale di Lugano, Lugano, Switzerland
    BMC Neurol 14:38. 2014
    ..The aim of this study was to evaluate satisfaction and adherence to treatment, behavioral and fatigue changes in patients switched to IFN B 1B compared to continued NTZ treatment...
  2. pmc Awareness of headache and of National Headache Society activities among primary care physicians - a qualitative study
    Andreas R Gantenbein
    Neurorehabilitation, RehaClinic Bad Zurzach, Quellenstrasse 34, Bad Zurzach, CH 5330, Switzerland
    BMC Res Notes 6:118. 2013
    ..The aim of the study was to investigate the potential contribution that national societies can make toward raising the awareness of primary headaches in general practice...
  3. pmc Interferon beta 1b following natalizumab discontinuation: one year, randomized, prospective, pilot trial
    Claudio Gobbi
    Neurocenter of Southern Switzerland, Ospedale Regionale di Lugano, Lugano, Switzerland
    BMC Neurol 13:101. 2013
    ..The objective of this study is to compare disease activity in MS patients who continued on NTZ treatment to those who were switched to subcutaneous interferon 1b (IFNB) treatment...
  4. ncbi request reprint Restless legs syndrome in multiple sclerosis
    Chiara Zecca
    Neurocenter of Southern Switzerland, Civic Hospital, Lugano, Switzerland
    CNS Neurol Disord Drug Targets 11:1061-9. 2012
    ....
  5. doi request reprint Percutaneous posterior tibial nerve stimulation as an effective treatment of refractory lower urinary tract symptoms in patients with multiple sclerosis: preliminary data from a multicentre, prospective, open label trial
    C Gobbi
    Neurocentre of Southern Switzerland, Ente Ospedaliero Cantonale, Ospedale Regionale di Lugano, Lugano, Switzerland
    Mult Scler 17:1514-9. 2011
    ..Percutaneous tibial nerve stimulation (PTNS) has been proposed as a new, minimally invasive neuromodulation technique to treat lower urinary tract symptoms (LUTS)...
  6. doi request reprint Maintenance percutaneous posterior nerve stimulation for refractory lower urinary tract symptoms in patients with multiple sclerosis: an open label, multicenter, prospective study
    C Zecca
    Neurocentre of Italian Switzerland, Lugano, Switzerland
    J Urol 191:697-702. 2014
    ..In this study we evaluate its effectiveness and propose an algorithm of percutaneous tibial nerve stimulation maintenance treatment in patients with multiple sclerosis...
  7. doi request reprint Motor and sensory responses after percutaneous tibial nerve stimulation in multiple sclerosis patients with lower urinary tract symptoms treated in daily practice
    C Zecca
    Neurocenter of Southern Switzerland, Ospedale Regionale di Lugano, Lugano, Switzerland
    Eur J Neurol 21:506-11. 2014
    ..Posterior tibial nerve stimulation (PTNS) is an effective treatment option for lower urinary tract symptoms (LUTS) in multiple sclerosis (MS) patients...